BioCentury
ARTICLE | Clinical News

Idera preclinical data

October 31, 2011 7:00 AM UTC

In mice, subcutaneous administration of Idera's gene-silencing oligonucleotide (GSO) targeting apolipoprotein B (APOB) reduced total serum cholesterol and LDL-C. GSOs are single-stranded RNA or DNA c...